Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ISOSORBIDE MONONITRATE Cause Product solubility abnormal? 6 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product solubility abnormal have been filed in association with ISOSORBIDE MONONITRATE (Isosorbide Mononitrate). This represents 0.2% of all adverse event reports for ISOSORBIDE MONONITRATE.

6
Reports of Product solubility abnormal with ISOSORBIDE MONONITRATE
0.2%
of all ISOSORBIDE MONONITRATE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Product solubility abnormal From ISOSORBIDE MONONITRATE?

Of the 6 reports, 1 (16.7%) required hospitalization.

Is Product solubility abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ISOSORBIDE MONONITRATE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does ISOSORBIDE MONONITRATE Cause?

Dizziness (554) Headache (500) Dyspnoea (462) Chest pain (458) Nausea (458) Fatigue (446) Diarrhoea (439) Pruritus (416) Myocardial infarction (409) Malaise (405)

What Other Drugs Cause Product solubility abnormal?

BUPRENORPHINE (498) BUPRENORPHINE\NALOXONE (274) POLYETHYLENE GLYCOL 3350 (220) CHOLESTYRAMINE (193) PATIROMER (107) LEVOTHYROXINE (100) SOMATROPIN (98) EXENATIDE (97) ESTRADIOL (94) NITROGLYCERIN (81)

Which ISOSORBIDE MONONITRATE Alternatives Have Lower Product solubility abnormal Risk?

ISOSORBIDE MONONITRATE vs ISOTRETINOIN ISOSORBIDE MONONITRATE vs ISRADIPINE ISOSORBIDE MONONITRATE vs ISTRADEFYLLINE ISOSORBIDE MONONITRATE vs ITACITINIB ISOSORBIDE MONONITRATE vs ITRACONAZOLE

Related Pages

ISOSORBIDE MONONITRATE Full Profile All Product solubility abnormal Reports All Drugs Causing Product solubility abnormal ISOSORBIDE MONONITRATE Demographics